Indoco Remedies Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Indoco Remedies Ltd. from all sources in a single place.

Load latest

Indoco Remedies Ltd.

29 Jul 2023

242.67

-7.23%

Company Update

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that on 29th July, 2023 at around 12.25 a.m. (IST), fire occurred at our warehouse and information technology (IT) office situated in the premises of our unit located at B-20, MIDC, Waluj, Aurangabad, Maharashtra- 431133 ("Plant").

pdf

Indoco Remedies Ltd.

28 Jul 2023

242.67

-7.23%

Earnings Call

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to the Regulation 30 read with Schedule III of the SEBI (LODR), Regulations, 2015, please find enclosed the transcript of Earnings Conference Call held on 25-07-2023 at 03:30 pm (IST) in respect of Unaudited Standalone & Consolidated Financial Results for the Qtr ended 30.06.2023.

pdf

Indoco Remedies Ltd.

27 Jul 2023

242.67

-7.23%

Buy Indoco Remedies; target of Rs 380: Prabhudas Lilladher

Moneycontrol

Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 380 in its research report dated July 25, 2023.

Indoco Remedies Ltd. average weekly volume is high.

Indoco Remedies Ltd.

26 Jul 2023

242.67

-7.23%

Company Update

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

NEWSPAPER PUBLICATION OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED 30-06-2023

pdf

Indoco Remedies Ltd.

26 Jul 2023

242.67

-7.23%

Company Update

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Company''s manufacturing facility for solid oral dosage form (Unit I) located at Baddi has received EU GMP Certification from Competent Health Authority of Malta confirming that the Facility complies with the Good Manufacturing Practice requirements as referred in the EC Directive. Please find enclosed press release in this regard.

pdf

Indoco Remedies Ltd.

25 Jul 2023

242.67

-7.23%

Earnings Call

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2023 held today i.e. 25th July, 2023 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04:15 p.m. (IST) on 25th July, 2023.

pdf

Indoco Remedies Ltd.

25 Jul 2023

242.67

-7.23%

to see Rapid results content

Indoco Remedies Ltd.

25 Jul 2023

242.67

-7.23%

Result

INDOCO REMEDIES LTD. - 532612 - Unaudited Standalone And Consolidated Financial Results For The Quarter Ended …

BSE India

Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we attach herewith the Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2023

pdf

Indoco Remedies Ltd.

25 Jul 2023

242.67

-7.23%

Result

INDOCO REMEDIES LTD. - 532612 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 25th July, 2023 has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2023 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.

pdf

Indoco Remedies Ltd.

18 Jul 2023

242.67

-7.23%

Company Update

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

This is to inform you that an Earnings Conference Call on Unaudited Financial Results for the quarter ended 30-06-2023 is scheduled to be held on 25-07-2023 at 03:30 pm IST.

pdf